FibroBiologics will present on fibroblast-based therapies for chronic diseases at a conference in Freiburg, Germany, on March 27, 2025. FibroBiologics, Inc., a biotechnology company focused on ...

In recent years, interest has grown around two investigational peptides, BPC-157 and TB-500, proposed as part of a combined research-oriented protocol to explore tissue regeneration, angiogenesis, and ...

Human lung fibroblasts stimulated with TGF-β1 to detect extracellular collagen I (pink), alpha-smooth muscle actin (α-SMA) (green), and cell nuclei (blue) as a measure of matrix production and ...

UCSF scientists engineered old fibroblast cells to turn their genes on and off in the same way as young fibroblasts. The old ...

This article is based on a poster originally authored by Fiona Leslie, Chloe Whiting, and Megan Webster. Idiopathic Pulmonary Fibrosis (IPF) is a chronic and progressive interstitial lung disease ...

CAFs Impact ECM and tumor growth: CAFs secrete MMPs to degrade ECM, releasing growth factors for cancer cells. ECM changes counteract CAFs and tumor cells: (a) Hard ECM triggers Twist release from ...

Biomedical researchers have decoded how mechanical forces drive cell behavior in fibrosis. The cells in human bodies are subject to both chemical and mechanical forces. But up until recently, ...

FSdC demonstrated statistically significant and superior improvement in disc preservation and structural integrity compared to other treatments ...